Author: Abeona Therapeutics Inc.

Posted Date:

April 7, 2026

Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

Abeona Therapeutics Inc.

April 7, 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Inc.

April 6, 2026
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

Abeona Therapeutics Inc.

April 2, 2026
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates

Abeona Therapeutics Inc.

March 17, 2026
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch

Abeona Therapeutics Inc.

March 9, 2026
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference

Abeona Therapeutics Inc.

March 3, 2026
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Inc.

February 9, 2026